ATOMIC BETA UK LIMITED

Company number 13180969 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ATOMIC BETA UK LIMITED - Analysis Report

Company Number: 13180969

Analysis Date: 2025-07-29 17:26 UTC

Financial Health Assessment for Atomic Beta UK Limited


1. Financial Health Score: C

Explanation:
Atomic Beta UK Limited has shown a significant turnaround from prior years' negative net current assets and shareholders’ funds to a positive financial position in the latest year. However, the company still exhibits early-stage financial fragility consistent with a young business recovering from initial losses. The modest cash reserves and reliance on debtors for liquidity raise caution. Overall, this company is on a path to recovery but remains vulnerable to operational or market shocks.


2. Key Vital Signs

Metric 2024 Value Interpretation
Current Assets £31,638 Healthy increase, mostly in debtors; indicates strong sales or receivables build-up.
Cash at Bank £100 Extremely low cash balance; risk of liquidity crunch if debtors delay payments.
Current Liabilities £14,145 Moderate short-term obligations; manageable with current assets but requires monitoring.
Net Current Assets £17,493 Positive working capital; symptom of improving liquidity health after past deficits.
Shareholders' Funds £17,493 Turned positive from negative; capital base strengthening but still relatively small.
Trend in Net Current Assets From -£22,398 (2021) to +£17,493 (2024) Indicates recovery from financial distress; good sign of operational improvement.
Turnover (not disclosed) Unknown Absence of turnover data limits assessment of profitability and cash generation capacity.
Employee Count 5 Small team, typical for a micro/small company; may limit operational scale and risk diversification.

Interpretation:

  • The company's liquidity—the "blood flow" of the business—is improving, as seen by the positive net current assets.
  • However, the "pulse" (cash holdings) is weak, with only £100 in cash, which is a symptom of a potential cash flow bottleneck.
  • The reliance on debtors (accounts receivable) as the main current asset suggests the company’s revenue is tied up in credit extended to customers.
  • Past years showed negative equity, a "symptom of distress," but the latest year’s positive equity suggests "healing" is underway.
  • The company remains vulnerable due to limited cash reserves and potential exposure if debtors delay payments.

3. Diagnosis

Atomic Beta UK Limited, incorporated in 2021, has demonstrated a financial recovery from an initial distressed state characterized by negative net current assets and shareholders’ funds. The current positive working capital and shareholders’ equity indicate improved operational performance or successful capital injection. However, the company’s extremely low cash reserves and heavy dependence on receivables point to ongoing liquidity risk. This is akin to a patient whose vital signs have improved but still requires close monitoring and support.

The lack of turnover and profit & loss data limits a full diagnosis of profitability and operational efficiency, which are critical to long-term sustainability. The company operates in market research and advertising—industries sensitive to economic cycles and client budget fluctuations—adding external risk factors. The small team size may constrain growth but also limits fixed costs.

Overall, the financial "heart" of the company is beating healthier than before, but the "circulatory system" (cash flow) is fragile. Without sufficient cash or rapid collection of receivables, the company could face short-term distress.


4. Recommendations

  1. Improve Cash Reserves:

    • Prioritize collecting outstanding receivables promptly to convert debtors into liquid cash.
    • Consider negotiating better payment terms with customers or incentivizing early payments.
  2. Cash Flow Management:

    • Implement rigorous cash flow forecasting and management to anticipate and mitigate liquidity gaps.
    • Explore short-term financing options (e.g., overdrafts or invoice financing) as a safety net to smooth cash flow.
  3. Build Profitability Insight:

    • Prepare and review detailed profit and loss statements regularly to identify cost drivers and revenue opportunities.
    • Consider seeking external advice to improve pricing strategy or operational efficiency.
  4. Strengthen Capital Base:

    • If feasible, inject additional equity or secure longer-term financing to reduce reliance on short-term liabilities.
  5. Monitor Operational Risks:

    • Given the industry exposure, diversify client base and revenue streams to reduce vulnerability from market fluctuations.
    • Maintain tight control over overheads to preserve financial flexibility.
  6. Compliance and Reporting:

    • Ensure timely and comprehensive financial reporting, including turnover and profitability disclosures, to support informed decision-making.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.